Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG
Friday, February 12, 2021MindMed a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent nextgen psychedelic compounds with psychedelic or empathogenic properties
I2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-based Medicines
Thursday, February 11, 2021IO Therapeutics developers of a platform for oral delivery of traditionally injectable biological drugs announced today a research collaboration with Sanofi to investigate the oral delivery of Sanofis Nanobodybased medicines which are currently admin...
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
Thursday, February 11, 2021Apollomics Inc an innovative biopharmaceutical company committed to the discovery and development of mono and combination oncology therapies and Iterion Therapeutics Inc a venturebacked
Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China
Wednesday, February 10, 2021Antibe Therapeutics Inc announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region Nuance is a biopharmaceutical company focused on licensing
Hangzhou Chance Pharmaceuticals Expands Pipeline with In-Licensing of AER901 from Aerami Therapeutics
Wednesday, February 10, 2021Hangzhou Chance Pharmaceuticals Chance a clinicalstage biotechnology company focusing on discovering developing and commercializing transformative inhalation therapies for the worlds most debilitating diseases
Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients
Tuesday, February 09, 2021Hoth Therapeutics Inc a biopharmaceutical company today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application for HT topical product to the...
Yingli Pharma and Hengrui Medicine Reach a Strategic Agreement to Jointly Explore the Oncology Market in China
Tuesday, February 09, 2021Yingli Pharma announced that it reached strategic collaboration with Hengrui Medicine SH a partnership which will significantly accelerate the expansion of Yingli Pharmas oncology business in China
AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson’s Disease
Monday, February 08, 2021AC Immune SA a Swissbased clinicalstage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases today announced that the first patient has been scanned in a firstinhuman study of its novel diagnostic agent
FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
Saturday, February 06, 2021The US Food and Drug Administration approved Breyanzi lisocabtagene maraleucel a cellbased gene therapy to treat adult patients with certain types of large Bcell lymphoma who have not responded to or who have relapsed after at least two other types o...
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S.
Saturday, February 06, 2021IMab a clinical stage biopharmaceutical company committed to the discovery development and commercialization of novel or highly differentiated biologics announced multiple clinical advancements for its proprietary and highly differentiated CD antibod...
